Abbott Laboratories (NYSE:ABT) will release its quarterly earnings report on Wednesday, 2024-10-16. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Abbott Laboratories to report an earnings per share (EPS) of $1.20.
The market awaits Abbott Laboratories's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Performance in Previous Earnings
The company's EPS beat by $0.04 in the last quarter, leading to a 1.96% increase in the share price on the following day.
Here's a look at Abbott Laboratories's past performance and the resulting price change:
Quarter
Q2 2024
Q1 2024
Q4 2023
Q3 2023
EPS Estimate
1.10
0.95
1.19
1.04
EPS Actual
1.14
0.98
1.19
1.14
Price Change %
2.0%
-1.0%
2.0%
-0.0%
Tracking Abbott Laboratories's Stock Performance
Shares of Abbott Laboratories were trading at $116.7 as of October 14. Over the last 52-week period, shares are up 22.48%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
Insights Shared by Analysts on Abbott Laboratories
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Abbott Laboratories.
With 9 analyst ratings, Abbott Laboratories has a consensus rating of Outperform. The average one-year price ...
